Discussion
All 33 girls and young women with Rett syndrome dosed with Taysha Gene Therapies‘ experimental gene therapy TSHA-102 across clinical trials have cleared the acute safety monitoring window, with no reported serious treatment-related adverse events or dose-limiting toxicities. These positive safety data were drawn from 29 girls and…